456 related articles for article (PubMed ID: 18445095)
1. Characteristics of symptomatic reflux episodes on Acid suppressive therapy.
Tutuian R; Vela MF; Hill EG; Mainie I; Agrawal A; Castell DO
Am J Gastroenterol; 2008 May; 103(5):1090-6. PubMed ID: 18445095
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
3. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.
Zerbib F; Roman S; Ropert A; des Varannes SB; Pouderoux P; Chaput U; Mion F; Vérin E; Galmiche JP; Sifrim D
Am J Gastroenterol; 2006 Sep; 101(9):1956-63. PubMed ID: 16848801
[TBL] [Abstract][Full Text] [Related]
4. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
[TBL] [Abstract][Full Text] [Related]
5. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
Sharma N; Agrawal A; Freeman J; Vela MF; Castell D
Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117
[TBL] [Abstract][Full Text] [Related]
6. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
7. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.
Savarino E; Zentilin P; Tutuian R; Pohl D; Casa DD; Frazzoni M; Cestari R; Savarino V
Am J Gastroenterol; 2008 Nov; 103(11):2685-93. PubMed ID: 18775017
[TBL] [Abstract][Full Text] [Related]
8. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers.
Shay S; Tutuian R; Sifrim D; Vela M; Wise J; Balaji N; Zhang X; Adhami T; Murray J; Peters J; Castell D
Am J Gastroenterol; 2004 Jun; 99(6):1037-43. PubMed ID: 15180722
[TBL] [Abstract][Full Text] [Related]
10. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
[TBL] [Abstract][Full Text] [Related]
11. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.
Blonski W; Vela MF; Castell DO
J Clin Gastroenterol; 2009 Oct; 43(9):816-20. PubMed ID: 19398927
[TBL] [Abstract][Full Text] [Related]
12. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of symptomatic reflux episodes in patients with non-erosive reflux disease who have a positive symptom index on proton pump inhibitor therapy.
Iwakiri K; Sano H; Tanaka Y; Kawami N; Umezawa M; Futagami S; Hoshihara Y; Nomura T; Miyashita M; Sakamoto C
Digestion; 2010; 82(3):156-61. PubMed ID: 20588027
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
[TBL] [Abstract][Full Text] [Related]
16. Nonacid reflux episodes reaching the pharynx are important factors associated with cough.
Patterson N; Mainie I; Rafferty G; McGarvey L; Heaney L; Tutuian R; Castell D; Johnston BT
J Clin Gastroenterol; 2009; 43(5):414-9. PubMed ID: 19197196
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
Savarino E; Tutuian R; Zentilin P; Dulbecco P; Pohl D; Marabotto E; Parodi A; Sammito G; Gemignani L; Bodini G; Savarino V
Am J Gastroenterol; 2010 May; 105(5):1053-61. PubMed ID: 19997095
[TBL] [Abstract][Full Text] [Related]
18. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
[TBL] [Abstract][Full Text] [Related]
19. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD).
Milkes D; Gerson LB; Triadafilopoulos G
Am J Gastroenterol; 2004 Jun; 99(6):991-6. PubMed ID: 15180715
[TBL] [Abstract][Full Text] [Related]
20. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
